Julie Zhen Qin Wu

Array ( [id] => 4879282 [patent_doc_number] => 20080152665 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-06-26 [patent_title] => 'THERAPY OF CANCER BASED ON TARGETING ADAPTIVE, INNATE AND/OR REGULATORY COMPONENT OF THE IMMUNE RESPONSE' [patent_app_type] => utility [patent_app_number] => 11/778267 [patent_app_country] => US [patent_app_date] => 2007-07-16 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 22 [patent_figures_cnt] => 22 [patent_no_of_words] => 17779 [patent_no_of_claims] => 57 [patent_no_of_ind_claims] => 31 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0152/20080152665.pdf [firstpage_image] =>[orig_patent_app_number] => 11778267 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5480022 [patent_doc_number] => 20090202979 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-08-13 [patent_title] => 'Production of antibody formats and immunological applications of said formats' [patent_app_type] => utility [patent_app_number] => 11/818218 [patent_app_country] => US [patent_app_date] => 2007-06-13 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 94 [patent_figures_cnt] => 94 [patent_no_of_words] => 15564 [patent_no_of_claims] => 25 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 11818218 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6343686 [patent_doc_number] => 20100248223 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-09-30 [patent_title] => 'ASSESSING OUTCOMES FOR BREAST CANCER PATIENTS' [patent_app_type] => utility [patent_app_number] => 12/301258 [patent_app_country] => US [patent_app_date] => 2007-05-18 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 23 [patent_figures_cnt] => 23 [patent_no_of_words] => 13857 [patent_no_of_claims] => 17 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0248/20100248223.pdf [firstpage_image] =>[orig_patent_app_number] => 12301258 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5277974 [patent_doc_number] => 20090130106 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-05-21 [patent_title] => 'DEMIBODIES: DIMERIZATION-ACTIVATED THERAPEUTIC AGENTS' [patent_app_type] => utility [patent_app_number] => 12/095468 [patent_app_country] => US [patent_app_date] => 2006-11-29 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 19 [patent_figures_cnt] => 19 [patent_no_of_words] => 11103 [patent_no_of_claims] => 37 [patent_no_of_ind_claims] => 8 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0130/20090130106.pdf [firstpage_image] =>[orig_patent_app_number] => 12095468 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7662275 [patent_doc_number] => 20110311544 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-12-22 [patent_title] => 'Anti-cd71 Monoclonal Antibodies and Uses Thereof for Treating Malignant Tumor Cells' [patent_app_type] => utility [patent_app_number] => 11/922025 [patent_app_country] => US [patent_app_date] => 2006-06-14 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 6 [patent_no_of_words] => 7245 [patent_no_of_claims] => 38 [patent_no_of_ind_claims] => 8 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0311/20110311544.pdf [firstpage_image] =>[orig_patent_app_number] => 11922025 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6007403 [patent_doc_number] => 20110059434 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-03-10 [patent_title] => 'P13k pathway mutations in cancer' [patent_app_type] => utility [patent_app_number] => 11/920860 [patent_app_country] => US [patent_app_date] => 2006-05-23 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 15 [patent_figures_cnt] => 15 [patent_no_of_words] => 4056 [patent_no_of_claims] => 75 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0059/20110059434.pdf [firstpage_image] =>[orig_patent_app_number] => 11920860 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 11277092 [patent_doc_number] => 09493569 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2016-11-15 [patent_title] => 'Structural isomers of sc(Fv)2' [patent_app_type] => utility [patent_app_number] => 11/910117 [patent_app_country] => US [patent_app_date] => 2006-03-31 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 34 [patent_figures_cnt] => 34 [patent_no_of_words] => 25149 [patent_no_of_claims] => 14 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 113 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 11910117 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 9607658 [patent_doc_number] => 08784821 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2014-07-22 [patent_title] => 'Human-anti-human cd3 binding molecules' [patent_app_type] => utility [patent_app_number] => 10/554731 [patent_app_country] => US [patent_app_date] => 2004-05-26 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 64 [patent_figures_cnt] => 27 [patent_no_of_words] => 41860 [patent_no_of_claims] => 23 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 688 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 10554731 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 10850526 [patent_doc_number] => 08877204 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2014-11-04 [patent_title] => 'Methods and compositions for the treatment of cancer and infectious disease using alpha (2) macroglobulin-antigenic molecule complexes' [patent_app_type] => utility [patent_app_number] => 10/546106 [patent_app_country] => US [patent_app_date] => 2004-02-20 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 15 [patent_no_of_words] => 28401 [patent_no_of_claims] => 15 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 119 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 10546106 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5631009 [patent_doc_number] => 20060147478 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-07-06 [patent_title] => 'Protein involved in carcinoma' [patent_app_type] => utility [patent_app_number] => 10/524910 [patent_app_country] => US [patent_app_date] => 2003-08-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 10 [patent_figures_cnt] => 10 [patent_no_of_words] => 18144 [patent_no_of_claims] => 32 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0147/20060147478.pdf [firstpage_image] =>[orig_patent_app_number] => 10524910 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7364841 [patent_doc_number] => 20040005645 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-01-08 [patent_title] => 'Protein markers for esophageal cancer' [patent_app_type] => new [patent_app_number] => 10/393992 [patent_app_country] => US [patent_app_date] => 2003-03-24 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 43 [patent_figures_cnt] => 43 [patent_no_of_words] => 4890 [patent_no_of_claims] => 7 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 22 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0005/20040005645.pdf [firstpage_image] =>[orig_patent_app_number] => 10393992 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6643089 [patent_doc_number] => 20030104014 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-06-05 [patent_title] => 'Method for the treatment of malignant and infectious chronic diseases' [patent_app_type] => new [patent_app_number] => 10/309015 [patent_app_country] => US [patent_app_date] => 2002-12-04 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 4 [patent_no_of_words] => 5279 [patent_no_of_claims] => 16 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 17 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0104/20030104014.pdf [firstpage_image] =>[orig_patent_app_number] => 10309015 [rel_patent_id] =>[rel_patent_doc_number] =>)